Heuron, a medical AI solution company, participates in the Asian-Oceanian Congress of Neuroradiology 2023 (AOCNR 2023), which is held in Singapore from August 18th. Heuron showcases its neurodegenerative disease AI solution such as Heuron AgingCare Suite, and its integrated stroke solution, Heuron StroCare Suite, to engage in global collaborations and partnerships. (Graphic: Business Wire)
KUALA LUMPUR, Aug 17 (Bernama) -- Heuron, a medical artificial intelligence (AI) solution company, announced its participation in the Asian-Oceanian Congress of Neuroradiology 2023 (AOCNR 2023) which will be held in Singapore from Aug 18-20.
An international academic conference organised by the Asian Oceanian Society of Neuroradiology, AOCNR gathers over a thousand medical professionals from Asia, Oceania, North America, Europe and the rest of the world.
Heuron Chief Executive Officer, Donghoon Shin said the company was seeing significant interests in its products from Asian countries, and actively expanding its business presence.
“At the AOCNR 2023, we aim to strongly enhance competitiveness of our products, and seek partnerships with various institutions and medical professionals through research collaborations, demo presentations, and more,” he said in a statement.
During this event, Heuron will showcase its neurodegenerative disease AI solution such as Heuron AgingCare Suite, and its integrated stroke solution, Heuron StroCare Suite, to engage in global collaborations and partnerships.
Heuron AgingCare Suite includes neurodegenerative diseases solutions for Parkinson's disease (Heuron IPD and Heuron NI), and Alzheimer's disease (Heuron AD and Heuron Brain PET).
Meanwhile, Heuron StroCare Suite is an integrated AI solution that enables one-stop classification of patients with cerebral hemorrhage and cerebral infarction with non-contrast computed tomography (CT).
Heuron offers diagnostic AI software that automatically quantitatively analyses neurodegenerative brain disorders' medical images including Parkinson's disease, dementia, and strokes to aid accurate and swift decision-making by medical professionals.
-- BERNAMA
No comments:
Post a Comment